Melissa Jane Buchan Globe Life Inc. (GL) insider trading activity

Melissa Jane Buchan is Director of GLOBE LIFE INC.. Currently has a direct ownership of 80,284 shares of GL, which is worth approximately $8.89 Million. The most recent transaction as insider was on Dec 12, 2023, when has been sold 1,000 shares (Common Stock) at a price of $124.5 per share, resulting in proceeds of $124,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 80.3K

0% 3M change

0% 12M change

Total Value Held $8.89 Million

MELISSA JANE BUCHAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 12 2023	SELL Open market or private sale	$124,500 $124.5 p/Share	1,000 Reduced 1.23%	80,284 Common Stock
Nov 21 2023	SELL Bona fide gift	-	10 Reduced 0.01%	81,284 Common Stock
Nov 16 2023	SELL Bona fide gift	-	425 Reduced 0.52%	81,294 Common Stock
Jun 30 2023	SELL Bona fide gift	-	235 Reduced 0.29%	81,423 Common Stock
Mar 16 2023	SELL Open market or private sale	$201,305 $105.95 p/Share	1,900 Reduced 2.27%	81,658 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	1,422 Added 1.67%	83,558 Common Stock
Nov 29 2022	SELL Bona fide gift	-	430 Reduced 0.52%	82,136 Common Stock
Jun 27 2022	SELL Bona fide gift	-	265 Reduced 0.32%	82,422 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	1,791 Added 2.12%	82,539 Common Stock
Dec 21 2021	SELL Bona fide gift	-	570 Reduced 0.7%	80,748 Common Stock
Nov 02 2021	SELL Open market or private sale	$156,536 $92.08 p/Share	1,700 Reduced 2.05%	81,170 Common Stock
Jun 02 2021	SELL Open market or private sale	$1,235,419 $105.89 p/Share	11,667 Reduced 12.34%	82,870 Common Stock
Jun 02 2021	BUY Exercise of conversion of derivative security	$631,885 $54.16 p/Share	11,667 Added 10.99%	94,537 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	-	1,732 Added 2.05%	82,732 Common Stock
Jan 02 2018	BUY Grant, award, or other acquisition	-	2,606 Added 3.15%	80,241 Common Strock

Also insider at

IMMX

Immix Biopharma, Inc. Healthcare

Director

MJB